Clinicopathological significance of tumor Cyclin D1 (cas 136601-57-5) expression in oral cancer
-
Add time:09/03/2019 Source:sciencedirect.com
ObjectiveTo evaluate the association of Cyclin D1 (cas 136601-57-5) overexpression with clinicopathological parameters classically considered of prognostic value in OSCC (T, N, M, clinical stage, degree of differentiation, invasive morphology and, cellular proliferation index).
We also recommend Trading Suppliers and Manufacturers of Cyclin D1 (cas 136601-57-5). Pls Click Website Link as below: cas 136601-57-5 suppliers
Prev:Experimental demonstrations of the earned dogmatism effect using a variety of optimal manipulations: Commentary and response to calin (cas 136601-43-9)-Jageman (2018)☆
Next:Activation of Cyclin D1 (cas 136601-57-5) affects mitochondrial mass following traumatic brain injury) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Cyclin D1 (cas 136601-57-5) is significantly associated with stage of tumor and predicts poor survival in endometrial carcinoma patients09/25/2019
- Schizophrenia susceptibility gene product dysbindin-1 regulates the homeostasis of Cyclin D1 (cas 136601-57-5)09/24/2019
- Original Article2,3,7,8-Tetrachlorodibenzo-p-dioxin Promotes Proliferation of Astrocyte Cells via the Akt/STAT3/Cyclin D1 (cas 136601-57-5) Pathway09/10/2019
- Cyclin D1 (cas 136601-57-5) silencing impairs DNA double strand break repair, sensitizes BRCA1 wildtype ovarian cancer cells to olaparib09/09/2019
- Original ArticlesCircNR3C1 inhibits proliferation of bladder cancer cells by sponging miR-27a-3p and downregulating Cyclin D1 (cas 136601-57-5) expression09/08/2019
- Original articleCyclin D1 (cas 136601-57-5) expression by histiocytes may mimic Cyclin D1 (cas 136601-57-5)-positive proliferation centres of chronic lymphocytic leukaemia/small lymphocytic lymphoma09/07/2019
- Asymmetrical proliferative pattern loss linked to Cyclin D1 (cas 136601-57-5) overexpression in adjacent non-tumour epithelium in oral squamous cell carcinoma09/06/2019
- MicroRNA-206 serves as a tumor suppressor in pediatric acute myeloid leukemia by targeting Cyclin D1 (cas 136601-57-5)09/05/2019
- Activation of Cyclin D1 (cas 136601-57-5) affects mitochondrial mass following traumatic brain injury09/04/2019
